NEUWIRTH, Radek, Jakub CVEK, Lukas KNYBEL, Otakar JIRAVSKÝ, Lukas MOLENDA, Michal KODAJ, Martin FIALA, Petr PEICHL, David FELTL, Jaroslav JANUSKA, Jan HECKO and Josef KAUTZNER. Stereotactic radiosurgery for ablation of ventricular tachycardia. EP Europace. Oxford: Oxford University Press, 2019, vol. 21, No 7, p. 1088-1095. ISSN 1099-5129. Available from: https://dx.doi.org/10.1093/europace/euz133.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Stereotactic radiosurgery for ablation of ventricular tachycardia
Authors NEUWIRTH, Radek (203 Czech Republic, belonging to the institution), Jakub CVEK (203 Czech Republic, guarantor), Lukas KNYBEL (203 Czech Republic), Otakar JIRAVSKÝ (203 Czech Republic), Lukas MOLENDA (203 Czech Republic), Michal KODAJ (203 Czech Republic), Martin FIALA (203 Czech Republic, belonging to the institution), Petr PEICHL (203 Czech Republic), David FELTL (203 Czech Republic), Jaroslav JANUSKA (203 Czech Republic), Jan HECKO (203 Czech Republic) and Josef KAUTZNER (203 Czech Republic).
Edition EP Europace, Oxford, Oxford University Press, 2019, 1099-5129.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.045
RIV identification code RIV/00216224:14110/19:00112603
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1093/europace/euz133
UT WoS 000493046000018
Keywords in English Ventricular tachycardia; Stereotactic body radiotherapy; Ablation
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 7/1/2021 14:47.
Abstract
Aims Stereotactic body radiotherapy (SBRT) for ventricular tachycardias (VTs) could be an option after failed catheter ablation. In this study, we analysed the long-term efficacy and toxicity of SBRT applied as a bail-out procedure. Methods and results Patients with structural heart disease and unsuccessful catheter ablations for VTs underwent SBRT. The planning target volume (PTV) was accurately delineated using exported 3D electroanatomical maps with the delineated critical part of re-entry circuits. This was defined by detailed electroanatomic mapping and by pacing manoeuvres during the procedure. Using the implantable cardioverter-defibrillator lead as a surrogate contrast marker for respiratory movement compensation, 25 Gy was delivered to the PTV using CyberKnife. We evaluated occurrences of sustained VT, electrical storm, antitachycardia pacing, and shock; time to death; and radiation-induced events. From 2014 until March 2017, 10 patients underwent radiosurgical ablation (mean PTV, 22.15 mL; treatment duration, 68 min). After radiosurgery, four patients experienced nausea and one patient presented gradual progression of mitral regurgitation. During the follow-up (median 28 months), VT burden was reduced by 87.5% compared with baseline (P = 0.012) and three patients suffered non-arrhythmic deaths. After the blanking period, VT recurred in eight of 10 patients. The mean time to first antitachycardia pacing and shock were 6.5 and 21 months, respectively. Conclusion Stereotactic body radiotherapy appears to show long-term safety and effectiveness for VT ablation in structural heart disease inaccessible to catheter ablation. We report one possible radiation-related toxicity and promising overall survival, warranting evaluation in a prospective multicentre clinical trial.
PrintDisplayed: 21/8/2024 08:59